Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

The unseen bleed- temporal and demographic patterns of thrombocytopenia mortality in the United States: A 25-year analysis of the CDC wonder database

View Full Paper
Ask AI
Bookmark
Share

Authors

BFBolivia Fernandes

Discussion

Loading...

Member takes

Overview

Observational analysis revealed rising mortality in adults due to thrombocytopenia, highlighting drug-induced factors.

Key Points

  • Mortality associated with thrombocytopenia rose significantly in the last 25 years, especially among males and non-metropolitan areas.
  • In 2023, the overall mortality rate reached 4.0 per 100,000, with key demographic disparities identified among NH Blacks and Alaskan Natives.
  • Analysis employed CDC WONDER data to assess mortality rates and demographic trends through age-adjusted metrics, revealing critical patterns.
  • These findings highlight the importance of targeted interventions for high-risk groups affected by drug-induced complications related to thrombocytopenia.

Cite This Study

Bolivia Fernandes (2025) studied this question.

synapsesocial.com/papers/69362f5d4fa91c937236dbc0https://doi.org/10.1182/blood-2025-6595
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Trends and disparities in immune thrombocytopenic purpura-related mortality in the United States: a retrospective study over 24 years2025
  2. 2Ethnic, racial, and geographic disparities in idiopathic thrombocytopenic purpura related mortality along the US-Mexico border from 1999 to 20202025
  3. 3Hemostasis in crisis: Two-decade trends of mortality due to coagulation defects in the u.S. population; A CDC- wonder database analysis2025
  4. 4Thrombotic thrombocytopenic purpura-related mortality trends among the United States population: A retrospective study using the CDC wonder database2025
  5. 5Trends in thromboembolism-related mortality among patients with hematologic malignancies in the u.S., 1999–2023: A CDC wonder analysis2025 · 1 citations